Fetal immune activation to malaria antigens enhances susceptibility to in vitro HIV infection in cord blood mononuclear cells

Journal of Infectious Diseases

Volumn 202, Issue 6, 2010, Pages 899-907

  Steiner, Kevin ^a   Myrie, Latoya ^a   Malhotra, Indu ^a   Mungai, Peter ^a,c   Muchiri, Eric ^c   Dent, Arlene ^a   King, Christopher L ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^c Division of Vector Borne Diseases   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; MALARIA ANTIGEN; PARASITE ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; EX VIVO STUDY; FEMALE; FETUS; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IN VITRO STUDY; INFECTION SENSITIVITY; KENYA; MALARIA; MONONUCLEAR CELL; MOTHER TO CHILD TRANSMISSION; NEWBORN; NORTH AMERICA; PRENATAL EXPOSURE; PRIORITY JOURNAL; SCHISTOSOMA HEMATOBIUM; UMBILICAL CORD BLOOD; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

ANIMALS; ANTIGENS, CD4; ANTIGENS, PROTOZOAN; DISEASE SUSCEPTIBILITY; FEMALE; FETAL BLOOD; HIV; HIV INFECTIONS; HLA-DR ANTIGENS; HUMANS; INFANT, NEWBORN; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; KENYA; LEUKOCYTES, MONONUCLEAR; MALARIA; PREGNANCY;

EID: 77955974468     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/655783     Document Type: Article

References (47)

1. Abu-Raddad L, Patnaik P, Kublin J. Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa. Science 2006; 314(5805):1603-1606.
2. UNAIDS. AIDS Epidemic Update: 2007. Geneva, Switzerland: UNAIDS, 2007.
3. Dreyfuss ML, Msamanga GI, Spiegelman D, Hunter DJ, Urassa EJ, Hertzmark E, Fawzi WW. Determinants of low birth weight among HIVinfected pregnant women in Tanzania. Am J Clin Nutr 2001; 74(6):814-826.
4. Zijenah L, Mbizvo M, Kasule J, et al. Mortality in the first 2 years among infants born to human immunodeficiency virus-infected women in Harare, Zimbabwe. J Infect Dis 1998; 178(1):109-113.
5. Taha TET, Dallabetta GA, Canner JK, et al. The effect of human immunodeficiency virus infection on birthweight, and infant and child mortality in urban Malawi. Int J Epidemiol 1995; 24(5):1022-1029.
6. Parise ME, Ayisi JG, Nahlen BL, et al. Efficacy of sulfadoxine- pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am J Trop Med Hyg 1998; 59(5):813-822.
7. Matteelli A, Caligaris S, Castelli F, Carosi G. The placenta and malaria. Ann Trop Med Parasitol 1997; 91(7):803-810.
8. Bulmer J, Rasheed F, Morrison L, Fancis N, Greenwood B. Placental malaria. II. A semi-quantitative investigation of the pathological features. Histopathology 1993; 22(3):219-225.
9. Inion I, Mwanyumba F, Gaillard P, et al. Placental malaria and perinatal transmission of human immunodeficiency virus type 1. J Infect Dis 2003; 188(11):1675-1678.
10. van Eijk A, Ayisi J, ter Kuile F, et al. HIV increases the risk of malaria in women of all gravidities in Kisumu, Kenya. AIDS 2003; 17(4):595-603.
11. Ladner J, Leroy V, Simonon A, et al. HIV infection, malaria, and pregnancy: A prospective cohort study in Kigali, Rwanda. Am J Trop Med Hyg 2002; 66(1):56-60.
12. ter Kuile F, Parise M, Verhoeff F, et al. The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-saharan Africa. Am J Trop Med Hyg 2004; 71(2 Suppl): 41-54.
13. Brahmbhatt H, Sullivan D, Kigozi G, et al. Association of HIV and malaria with mother-to-child transmission, birth outcomes, and child mortality. J Acquir Immune Defic Syndr 2008; 47(4):472-476.
14. Ticconi C, Mapfumo M, Dorrucci M, et al. Effect of maternal HIV and malaria infection on pregnancy and perinatal outcome in Zimbabwe. J Acquir Immune Defic Syndr 2003; 34(3):289-294.
15. Ayisi JG, van Eijk AM, ter Kuile FO, et al. The effect of dual infection with HIV and malaria on pregnancy outcome in western Kenya. AIDS 2003; 17(4):585-594.
16. Mwapasa V, Rogerson S, Molyneux M, et al. The effect of Plasmodium falciparum malaria on peripheral and placental HIV-1 RNA concentrations in pregnant Malawian women. AIDS 2004; 18(7):1051-1059.
17. Kublin JG, Patnaik P, Jere CS, et al. Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study. Lancet 2005; 365(9455):233-240.
18. Fawzi W, Msamanga G, Renjifo B, et al. Predictors of intrauterine and intrapartum transmission of HIV-1 among Tanzanian women. AIDS 2001; 15(9):1157-1165.
19. Mofenson LM, Lambert JS, Stiehm ER, et al. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. N Engl J Med 1999; 341(6):385-393.
20. Ned R, Moore J, Chaisavaneeyakorn S, Udhayakumar V. Modulation of immune responses during HIV-malaria co-infection in pregnancy. Trends Parasitol 2005; 21(6):284-291.
21. Brahmbhatt H, Kigozi G, Wabwire-Mangen F, et al. The effects of placental malaria on mother-to-child HIV transmission in Rakai, Uganda.AIDS 2003; 17(17):2539-2541.
22. Ayouba A, Nerrienet E, Menu E, et al. Mother-to-child transmission of human immunodeficiency virus type 1 in relation to the season in Yaounde, Cameroon. Am J Trop Med Hyg 2003; 69(4):447-449.
23. Ayisi J, van Eijk A, Newman R, et al. Maternal malaria and perinatal HIV transmission, western Kenya. Emerg Infect Dis 2004; 10(4):643-652.
24. Zack J, Arrigo S, Weitsman S, Go A, Haislip A, Chen I. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 1990; 61(2):213-222.
25. Zack J, Haislip A, Krogstad P, Chen I. Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle. J Virol 1992; 66(3): 1717-1725.
26. Malhotra I, Ouma J, Wamachi A, et al. In utero exposure to helminth and mycobacterial antigens generates cytokine responses similar to that observed in adults. J Clin Invest 1997; 99(7):1759-1766.
27. Ismaili J, van der Sande M, Holland M, et al. Plasmodium falciparum infection of the placenta affects newborn immune responses. Clin Exp Immunol 2003; 133(3):414-421.
28. Malhotra I, Mungai P, Muchiri E, et al. Distinct Th1- and Th2-Type prenatal cytokine responses to Plasmodium falciparum erythrocyte invasion ligands. Infect Immun 2005; 73(6):3462-3470.
29. Xi G, Leke R, Thuita L, et al. Congenital exposure to Plasmodium falciparum antigens: prevalence and antigenic specificity of in uteroproduced antimalarial immunoglobulin M antibodies. Infect Immun 2003; 71(3):1242-1246.
30. Malhotra I, Mungai P, Muchiri E, Kwiek J, Meshnick S, King C. Umbilical cord-blood infections with Plasmodium falciparum Malaria Are Acquired Antenatally in Kenya. J Infect Dis 2006; 194(2):176-183.
31. Gallagher M, Malhotra I, Mungai P, et al. The effects of maternal helminth and malaria infections on mother-to-child HIV transmission. AIDS 2005; 19(16):1849-1855.
32. Malhotra I, Dent A, Mungai P, et al. Can prenatal malaria exposure produce an immune tolerant phenotype?: a prospective birth cohort study in Kenya. PLoS Med 2009; 6(7):e1000116.
33. Malhotra I, Wamachi AN, Mungai PL, et al. Fine specificity of neonatal lymphocytes to an abundant malaria blood-stage antigen: epitope mapping of Plasmodium falciparum MSP133. J Immunol 2008; 180(5):3383-3390.
34. Ostrowski M, Chun T, Cheseboro B, Stanley S, Tremblay M. Unit 12.5: detection assays for HIV proteins. In: Current protocols in immunology. New York, NY: John Wiley & Sons, 2007.
35. Battke F, Symons S, Nieselt K. Mayday- integrative analytics for expression data. BMC Bioinformatics 2010; 11(1):121.
36. May K, Grube M, Malhotra I, et al. Antibody-dependent transplacental transfer of malaria blood-stage antigen using a human ex vivo placental perfusion model. PLoS ONE 2009; 4(11):e7986.
37. Wu L, PaxtonWA, Kassam N, et al. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1 in vitro. J Exp Med 1997; 185(9):1681-1692.
38. Paxton WA, Liu R, Kang S, et al. Reduced HIV-1 infectability of CD4+ lymphocytes from exposed-uninfected individuals: association with low expression of CCR5 and high production of [beta]-chemokines. Virology 1998; 244(1):66-73.
39. Lawn S, Butera S, Folks T. Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection. Clin Microbiol Rev 2001; 14(4):753-777.
40. Chuachoowong R, Shaffer N, SiriwasinW, et al. Short-course antenatal zidovudine reduces both cervicovaginal human immunodeficiency virus type 1 RNA levels and risk of perinatal transmission. J Infect Dis 2000; 181(1):99-106.
41. John G, Nduati R, Mbori-Ngacha D, et al. Correlates of mother-tochild human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1DNA shedding, and breast infections. J Infect Dis 2001; 183(2):206-212.
42. Tuomala R, O'Driscoll P, Bremer J, et al. Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women. J Infect Dis 2003; 187(3):375-384.
43. Van de Perre P. Mother-to-child transmission of HIV-1: the 'all mucosal' hypothesis as a predominant mechanism of transmission. AIDS 1999; 13(9):1133-1138.
44. Gaillard P, Verhofstede C, Mwanyumba F, et al. Exposure to HIV-1 during delivery and mother-to-child transmission. AIDS 2000; 14(15): 2341-2348.
45. Pope M, Haase AT. Transmission, acute HIV-1 infection and the quest for strategies to prevent infection. Nat Med 2003; 9(7):847-852.
46. Schacker T, Little S, Connick E, et al. Rapid accumulation of human immunodeficiency virus (HIV) in lymphatic tissue reservoirs during acute and early HIV infection: implications for timing of antiretroviral therapy. J Infect Dis 2000; 181(1):354-357.
47. Schacker T, Little S, Connick E, et al. Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection. J Infect Dis 2001; 183(4):555-562.